During pregnancy, the energy requirements of the fetus impose changes in maternal metabolism.
Increasing insulin resistance in the mother maintains nutrient flow to the growing fetus, …

Monoclonal antibodies (mAbs) targeting the immune checkpoint anti–programmed cell death
protein 1 (aPD-1) have demonstrated impressive benefits for the treatment of some cancers…

Binding of programmed death ligand-1 (PD-L1) to programmed cell death protein-1 (PD1)
leads to cancer immune evasion via inhibition of T cell function. One of the defining …

Therapeutic nanoparticles (TNPs) aim to deliver drugs more safely and effectively to cancers,
yet clinical results have been unpredictable owing to limited in vivo understanding. Here …

Therapeutic nanoparticles (TNPs) have shown heterogeneous responses in human clinical
trials, raising questions of whether imaging should be used to identify patients with a higher …

Pancreatic ductal adenocarcinoma (PDAC) is usually detected late in the disease process.
Clinical workup through imaging and tissue biopsies is often complex and expensive due to a …

Exosomes and extracellular vesicles (EV) are increasingly being explored as circulating
biomarkers, but their heterogenous composition will likely mandate the development of …

Despite many refinements in current therapeutic strategies, the overall prognosis for a patient
with glioblastoma is dismal. Neural precursor cells (NPCs) are capable of tracking glioma …

The global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has resulted in a critical need to rapidly develop new pharmacologic interventions and …

Tumor cell–derived extracellular vesicles (EVs) are being explored as circulating biomarkers,
but it is unclear whether bulk measurements will allow early cancer detection. We …